Medical
Moderna Soars on $14 Billion Cancer Vaccine Breakthrough Hopes
Moderna shares jumped 14 percent on October 9, 2026, after reports that the NIH plans a major public-private…
Moderna shares jumped 14 percent on October 9, 2026, after reports that the NIH plans a major public-private…
The NIH plans a December launch of a public-private partnership to personalized cancer vaccines, aiming for doctor's-office availability…